DERM
NASDAQ · Pharmaceuticals
Journey Medical Corp
$5.07
+0.07 (+1.40%)
Open$4.98
Previous Close$5.00
Day High$5.10
Day Low$4.84
52W High$9.56
52W Low$4.31
Volume—
Avg Volume166.7K
Market Cap136.65M
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+208.9% upside
Current
$5.07
$5.07
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 68.06M | 72.14M | 106.46M |
| Net Income | -12,576,433 | -11,997,869 | 19.04M |
| Profit Margin | -18.5% | -17.6% | 17.9% |
| EBITDA | -4,307,145 | -4,337,277 | 19.03M |
| Free Cash Flow | — | — | 11.82M |
| Rev Growth | -5.7% | -5.7% | +23.5% |
| Debt/Equity | 0.79 | 0.79 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |